I heard a rumor that Illumina is opening a 100 HiSeq 2500 service company in the Bay Area. Does anyone know if this is true? If so, it will put everyone else out of business including BGI.
-
-
I've not heard any rumors of Illumina setting up a new company, but they've publicly stated that they will be expanding their sequencing services capacity by reopening the services group that used to exist in Hayward. Perhaps that's the source of the rumor? -
Yes, it's in Hayward but not open yet. They are focusing on human genome sequencing and Moleculo sequencing. I guess they want to put BGI's Complete Genomics company and PacBio out of business.Comment
-
I guess I wouldn't call that a new company, just an obvious extension of the service business they already run. They've been doing anything they can to hurt CG for a long time now, and Moleculo is another weapon for them. It's not yet clear to me exactly how damaging this will be for PacBio. I guess time will tell...Comment
-
NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...Yesterday, 06:46 AM -
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...10-14-2026, 09:55 AM
Comment